Total Payments
$250,962
2024 Payments
$10,980
Companies
57
Transactions
823
Medicare Patients
462
Medicare Billing
$44,901
Payment Breakdown by Category
Other$193,259 (77.0%)
Travel$35,025 (14.0%)
Food & Beverage$16,017 (6.4%)
Consulting$6,660 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $103,400 | 32 | 41.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $89,859 | 50 | 35.8% |
| Travel and Lodging | $35,025 | 101 | 14.0% |
| Food and Beverage | $16,017 | 636 | 6.4% |
| Consulting Fee | $6,660 | 4 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $127,811 | 166 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $84,867 | 177 | $0 (2022) |
| Eisai Inc. | $30,566 | 82 | $0 (2024) |
| UCB, Inc. | $1,587 | 66 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $969.96 | 62 | $0 (2024) |
| ABBVIE INC. | $756.75 | 48 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $361.83 | 17 | $0 (2024) |
| Lundbeck LLC | $252.68 | 13 | $0 (2022) |
| Acorda Therapeutics, Inc | $242.87 | 13 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $229.09 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,980 | 82 | SK Life Science, Inc. ($9,671) |
| 2023 | $20,854 | 91 | SK Life Science, Inc. ($19,397) |
| 2022 | $40,225 | 116 | SK Life Science, Inc. ($33,820) |
| 2021 | $42,129 | 86 | SK Life Science, Inc. ($33,024) |
| 2020 | $33,507 | 92 | SK Life Science, Inc. ($31,898) |
| 2019 | $8,329 | 83 | EISAI INC. ($6,475) |
| 2018 | $28,644 | 116 | Sunovion Pharmaceuticals Inc. ($26,684) |
| 2017 | $66,295 | 157 | Sunovion Pharmaceuticals Inc. ($54,084) |
All Payment Transactions
823 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $40.25 | General |
| Category: Neurology | ||||||
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $0.29 | General |
| Category: Neurology | ||||||
| 12/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $48.62 | General |
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: Rare Disease | ||||||
| 12/02/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Neurology | ||||||
| 11/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.00 | General |
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Neurology | ||||||
| 11/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.77 | General |
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: RETT SYNDROME | ||||||
| 10/01/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Neurology | ||||||
| 09/30/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Neurology | ||||||
| 09/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Neurology | ||||||
| 09/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: Neurology | ||||||
| 09/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Neurology | ||||||
| 09/19/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $4,200.00 | General |
| Category: Neurology | ||||||
| 09/19/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $439.48 | General |
| Category: Neurology | ||||||
| 09/19/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $136.04 | General |
| Category: Neurology | ||||||
| 09/19/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Neurology | ||||||
| 09/18/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $2,800.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 52 | 59 | $18,440 | $5,327 |
| 2022 | 4 | 81 | 96 | $21,054 | $5,721 |
| 2021 | 7 | 149 | 180 | $57,485 | $16,431 |
| 2020 | 8 | 180 | 220 | $65,006 | $17,422 |
Total Patients
462
Total Services
555
Medicare Billing
$44,901
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 29 | $7,453 | $2,197 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $5,865 | $1,860 | 31.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $5,122 | $1,271 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 47 | $12,079 | $3,325 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 25 | $4,375 | $1,198 | 27.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $2,730 | $711.41 | 26.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 11 | 11 | $1,870 | $485.88 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 53 | $13,621 | $4,481 | 32.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 16 | 16 | $15,968 | $4,174 | 26.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 22 | $7,590 | $2,445 | 32.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $7,486 | $2,019 | 27.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 21 | $4,410 | $1,179 | 26.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 18 | 19 | $3,230 | $856.90 | 26.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 16 | $2,800 | $641.47 | 22.9% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 13 | 14 | $2,380 | $634.90 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 67 | $17,219 | $4,691 | 27.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 12 | 12 | $11,976 | $3,028 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 35 | $7,350 | $2,001 | 27.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $6,698 | $1,825 | 27.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 17 | $6,009 | $1,729 | 28.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $5,820 | $1,571 | 27.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 33 | $5,854 | $1,476 | 25.2% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 12 | 13 | $2,210 | $596.45 | 27.0% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 11 | 11 | $1,870 | $502.87 | 26.9% |
About Dr. Dean Naritoku, M.D
Dr. Dean Naritoku, M.D is a Neurology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386625507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dean Naritoku, M.D has received a total of $250,962 in payments from pharmaceutical and medical device companies, with $10,980 received in 2024. These payments were reported across 823 transactions from 57 companies. The most common payment nature is "Honoraria" ($103,400).
As a Medicare-enrolled provider, Naritoku has provided services to 462 Medicare beneficiaries, totaling 555 services with total Medicare billing of $44,901. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Mobile, AL
- Active Since 11/07/2005
- Last Updated 02/22/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386625507
Products in Payments
- XCOPRI (Drug) $100,079
- APTIOM (Drug) $84,891
- Fycompa (Drug) $30,512
- Cenobamate (Drug) $25,273
- GILENYA (Drug) $615.88
- Briviact (Drug) $533.54
- BOTOX (Biological) $369.84
- Vimpat (Drug) $253.33
- Fintepla (Drug) $237.29
- KESIMPTA (Drug) $212.78
- ULTOMIRIS (Biological) $193.19
- ONFI (Drug) $190.45
- Epidiolex (Drug) $178.03
- OXTELLAR XR (Drug) $173.87
- VALTOCO (Drug) $168.60
- ACTIVA (Device) $153.18
- EPIDIOLEX (Drug) $152.95
- QULIPTA (Drug) $152.32
- INBRIJA (Drug) $146.71
- Nayzilam (Drug) $137.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Mobile
Dr. Daniel Dees, M.d, M.D
Neurology — Payments: $803,515
Neurology $803,515
Dr. Hayden Long, Md, MD
Neurology — Payments: $295,347
Neurology $295,347
Dr. Charles Markle, M.d, M.D
Neurology — Payments: $265,994
Neurology $265,994
Bassam Bassam, Md, MD
Neurology — Payments: $139,121
Neurology $139,121
Dr. Juan Ochoa, Md, MD
Neurology — Payments: $88,415
Neurology $88,415
Laura Minto, Md, MD
Neurology — Payments: $83,902
Neurology $83,902